Chemical Research in Chinese Universities ›› 2023, Vol. 39 ›› Issue (1): 72-82.doi: 10.1007/s40242-023-2349-1

• Review • Previous Articles     Next Articles

Enzymes in Nanomedicine for Anti-tumor Therapy

ZHOU Tong1, YUAN Shuaiqi1, QIAN Pinrong2, WU Yuzhou1   

  1. 1. Hubei Engineering Research Center for Biomaterials and Medical Protective Materials, Hubei Key Laboratory of Bioinorganic Chemistry & Materia Medica, Key Laboratory of Material Chemistry for Energy Conversion and Storage, Ministry of Education, School of Chemistry and Chemical Engineering, Huazhong University of Science and Technology, Wuhan, 430074, P. R. China;
    2. College of Life Science and Technology, Huazhong University of Science and Technology, Wuhan, 430074, P. R. China
  • Received:2022-12-18 Online:2023-02-01 Published:2023-02-02
  • Contact: WU Yuzhou E-mail:wuyuzhou@hust.edu.cn
  • Supported by:
    This work was supported by the National Key R&D Program of China(No. 2018YFA0903500), the Fundamental Research Funds for the Central Universities, China(No. 2022JYCXJJ056) and the Max Planck Partner Group.

Abstract: Natural enzymes are biological macromolecules catalyzing reactions in living organisms and regulating biological processes. Targeted delivery of enzymes into tumor tissues for anti-tumor therapy through nanotechnology has attracted emerging interest in recent years. In this paper, we systematically summarize the latest research progress on enzymes that used for anti-tumor therapy in nanomedicine with different action mechanisms, including anti-tumor principles, delivery modes, response modes, and synergistic therapeutic design of these enzymes. Finally, we discuss the challenges and future prospects of enzymes for anti-tumor nanomedicine.

Key words: Enzyme, Nanomedicine, Protein delivery, Cancer therapy